Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs RAYMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VAISHALI PHARMA RAYMED LABS VAISHALI PHARMA /
RAYMED LABS
 
P/E (TTM) x 25.7 -7.1 - View Chart
P/BV x 4.6 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VAISHALI PHARMA    RAYMED LABS
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
RAYMED LABS
Mar-23
VAISHALI PHARMA /
RAYMED LABS
5-Yr Chart
Click to enlarge
High Rs1942 9,497.5%   
Low Rs641 4,318.8%   
Sales per share (Unadj.) Rs66.00-  
Earnings per share (Unadj.) Rs6.3-0.4 -1,563.1%  
Cash flow per share (Unadj.) Rs6.7-0.4 -1,743.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.3-5.4 -578.7%  
Shares outstanding (eoy) m10.554.27 247.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.00-  
Avg P/E ratio x20.6-4.4 -467.3%  
P/CF ratio (eoy) x19.1-4.6 -420.2%  
Price / Book Value ratio x4.1-0.3 -1,262.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,3618 18,044.2%   
No. of employees `000NANA-   
Total wages/salary Rs m130 3,423.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6970-  
Other income Rs m220 10,614.3%   
Total revenues Rs m7190 342,342.9%   
Gross profit Rs m94-2 -5,041.9%  
Depreciation Rs m50 10,080.0%   
Interest Rs m230-   
Profit before tax Rs m88-2 -5,173.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m220-   
Profit after tax Rs m66-2 -3,862.0%  
Gross profit margin %13.50- 
Effective tax rate %25.40-   
Net profit margin %9.50- 
BALANCE SHEET DATA
Current assets Rs m7270 1,453,420.0%   
Current liabilities Rs m3211 35,631.1%   
Net working cap to sales %58.30- 
Current ratio x2.30.1 4,079.1%  
Inventory Days Days180- 
Debtors Days Days2,8090- 
Net fixed assets Rs m612 4,028.5%   
Share capital Rs m10543 246.7%   
"Free" reserves Rs m224-66 -340.9%   
Net worth Rs m330-23 -1,429.8%   
Long term debt Rs m520-   
Total assets Rs m7882 50,484.0%  
Interest coverage x4.90-  
Debt to equity ratio x0.20-  
Sales to assets ratio x0.90-   
Return on assets %11.2-109.5 -10.3%  
Return on equity %20.07.4 270.2%  
Return on capital %29.17.4 392.4%  
Exports to sales %25.20-  
Imports to sales %7.80-  
Exports (fob) Rs m176NA-   
Imports (cif) Rs m54NA-   
Fx inflow Rs m1760-   
Fx outflow Rs m550-   
Net fx Rs m1210-   
CASH FLOW
From Operations Rs m11-2 -658.5%  
From Investments Rs m32 172.0%  
From Financial Activity Rs m-17NA-  
Net Cashflow Rs m-40-  

Share Holding

Indian Promoters % 26.6 28.4 93.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.4 71.6 102.4%  
Shareholders   9,181 1,498 612.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VAISHALI PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VAISHALI PHARMA vs RAYMED LABS.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VAISHALI PHARMA vs RAYMED LABS. Share Price Performance

Period VAISHALI PHARMA RAYMED LABS.
1-Day -4.34% 0.00%
1-Month -4.79% 3.32%
1-Year -3.51% 6.86%
3-Year CAGR 62.23% 31.90%
5-Year CAGR 39.78% -1.90%

* Compound Annual Growth Rate

Here are more details on the VAISHALI PHARMA share price and the RAYMED LABS. share price.

Moving on to shareholding structures...

The promoters of VAISHALI PHARMA hold a 26.6% stake in the company. In case of RAYMED LABS. the stake stands at 28.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VAISHALI PHARMA and the shareholding pattern of RAYMED LABS..

Finally, a word on dividends...

In the most recent financial year, VAISHALI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

RAYMED LABS. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of VAISHALI PHARMA , and the dividend history of RAYMED LABS..



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.